e-learning
resources
Virtual 2021
07.09.2021
Late breaking basic and translational science of SARS-Cov2 and COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Increased Substance P levels in COVID-19 hospitalized patients
S. Smieszek (Washington, United States of America)
Source:
Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session:
Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session type:
Oral Presentation
Number:
4114
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Smieszek (Washington, United States of America). Late Breaking Abstract - Increased Substance P levels in COVID-19 hospitalized patients. 4114
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019
Late Breaking Abstract - Frequency and characteristics of TB relapses
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Late Breaking Abstract - Pulmonary function in children and adolescents after COVID-19
Source: Virtual Congress 2021 – Best of paediatric physiology and sleep research
Year: 2021
Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017
Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - Outpatient pulmonary rehabilitation in patients with long COVID
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Characterization of hospitalized patients with Influenza: a retrospective study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Late Breaking Abstract - Hospitalized patients aged =70 years were disproportionately affected by COVID-19
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021
Late Breaking Abstract - Long COVID-19 symptoms including fatigue are more frequent in females independently of COVID-19 treatment
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED).
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept